ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

FY’78 Construction Requests $44 Million, Budget At $12 Million

December 2, 1977

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

Senators Urge study section On Clinical Cancer Research

February 4, 1994

Zeneca Buys 50% Stake In Salick, Gets Managed Care Access

January 6, 1995

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996